The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 151.90
Bid: 153.40
Ask: 153.70
Change: 0.70 (0.46%)
Spread: 0.30 (0.196%)
Open: 155.00
High: 162.30
Low: 151.50
Prev. Close: 151.20
AML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

9 Nov 2022 15:33

RNS Number : 8784F
Aston Martin Lagonda Glob.Hldgs PLC
09 November 2022
 

9 November 2022

Aston Martin Lagonda Global Holdings plc

Notification of transactions by Directors, Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them

Aston Martin Lagonda Global Holdings plc (the "Company") announces the following changes in the interests of Directors in the Ordinary Shares in the Company ("Shares"), which took place on 8 November 2022.

Buy-out Share Award

On 8 November 2022, Doug Lafferty (Chief Financial Officer) was granted 659,113 Shares for nil-consideration, the "Buy-out Share Award".

The Buy-out Share Award vested immediately and was settled partly with 349,329 Shares and partly with cash (with the cash element being paid to HMRC to satisfy the income tax and National Insurance due on the award).

Doug is required to retain at least 75% of the 349,329 Shares he received, in accordance with the Company's Executive Directors' shareholding guidelines.

In order to secure Mr Lafferty's appointment and to allow him to join the Company at the earliest opportunity (and as disclosed both on appointment and in the 2021 Directors' Remuneration Report), the Remuneration Committee agreed to buy out awards that Doug forfeited on leaving his previous employer. This buy-out share award compensates Doug for an LTIP award at his previous employer which he forfeited by joining Aston Martin. This Buy-out Share Award was structured to reflect the actual outcome (determined by the previous employer) of the forfeited LTIP award and will be disclosed in full in the 2022 Directors' Remuneration Report.

The Buy-out Share Award is subject to clawback provisions and Doug will be required to repay the award if he resigns or his employment is terminated for cause within 12 months of the award date.

 

 

 

Enquiries:

 

Investors and Analysts

Sherief Bakr,

Director of Investor Relations

 

 

+44 (0)7789 177547

sherief.bakr@astonmartin.com

Media

Kevin Watters,

Director of Communications

 

 

 +44 (0)7764 386683

kevin.watters@astonmartin.com

Grace Barnie,

Corporate Communications Manager

 

 +44 (0)7880 903490

grace.barnie@astonmartin.com

Tulchan Communications

Harry Cameron and Simon Pilkington

 

+44 (0)20 73534200

 

 

Notification of transactions by Directors, Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Doug Lafferty

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aston Martin Lagonda Global Holdings plc

b)

LEI

213800167WOVOK5ZC776

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrumentIdentification code

Ordinary Shares

 

(ISIN: GB00BN7CG237)

b)

Nature of the transaction

Grant of Buy-out Award

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0

659,113

d)

Aggregated information- Aggregated volume

- Price

659,113

£0

e)

Date of the transaction

8 November 2022

f)

Place of the transaction

Outside a trading venue

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrumentIdentification code

Ordinary Shares

 

(ISIN: GB00BN7CG237)

b)

Nature of the transaction

Vesting of Buy-out Award - settled partly by way of Ordinary Shares and partly in cash

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0

349,329

d)

Aggregated information- Aggregated volume

- Price

349,329

£0

e)

Date of the transaction

8 November 2022

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUBDBBXGDGDC
Date   Source Headline
8th Apr 20249:00 amRNSAnnual Report 2023 and Notice of AGM
28th Mar 20244:10 pmRNSDirector Declaration
22nd Mar 20248:28 amRNSAppointment of New Chief Executive Officer
13th Mar 20246:16 pmRNSSuccessful pricing of £1.15 billion refinancing
12th Mar 20243:33 pmRNSHolding(s) in Company
11th Mar 20247:36 amRNSLaunch of Notes Offering
4th Mar 20249:05 amRNSIssue of equity to satisfy share awards
28th Feb 20247:00 amRNSPreliminary Results year ended 31 December 2023
20th Dec 20239:32 amRNSHolding(s) in Company
20th Dec 20239:31 amRNSHolding(s) in Company
8th Nov 20233:46 pmRNSHolding(s) in Company
8th Nov 20233:41 pmRNSHolding(s) in Company
8th Nov 20238:00 amRNSHolding(s) in Company
7th Nov 20233:23 pmRNSHolding(s) in Company
3rd Nov 202310:18 amRNSDirector/PDMR Shareholding
2nd Nov 20238:00 amRNSAdmission of shares and total voting rights
1st Nov 20237:00 amRNS3rd Quarter Results
30th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20232:14 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:13 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:10 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:10 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:07 pmRNSHolding(s) in Company
29th Sep 20237:00 amRNSIncreased investment by Yew Tree Consortium
19th Sep 202311:53 amRNSResult of Meeting
29th Aug 202312:01 pmRNSPublication of Circular and Notice of GM
4th Aug 20234:45 pmRNSHolding(s) in Company
4th Aug 20231:05 pmRNSDirector/PDMR Shareholding
4th Aug 202312:43 pmRNSDirector/PDMR Shareholding
4th Aug 202312:33 pmRNSDirector/PDMR Shareholding
4th Aug 202312:32 pmRNSDirector/PDMR Shareholding
4th Aug 202312:21 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSResult of Equity Issue
31st Jul 20234:41 pmRNSRetail Offer
31st Jul 20234:40 pmRNSProposed Share Placing
28th Jul 20237:00 amRNSAppointment of Non-executive Director
26th Jul 20232:49 pmRNSTotal Voting Rights
26th Jul 20237:00 amRNSHalf-year Report
14th Jul 202312:18 pmRNSHolding(s) in Company
10th Jul 20234:34 pmRNSReplacement Listing and Total Voting Rights
10th Jul 20238:56 amRNSAdditional Listing and Total Voting Rights
6th Jul 20238:16 amRNSHolding(s) in Company
3rd Jul 20237:00 amRNSAdmission of New Shares for Warrant exercise
27th Jun 20237:00 amRNSCapital Markets Day 2023
26th Jun 20237:00 amRNSAston Martin Lagonda and Lucid Group, Inc.
26th Jun 20237:00 amRNSAston Martin Lagonda and Mercedes-Benz AG
31st May 20239:18 amRNSHolding(s) in Company
30th May 202310:44 amRNSHolding(s) in Company
30th May 202310:39 amRNSHolding(s) in Company
30th May 20238:46 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.